Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Mesoblast Ltd Ads (MESO)

17.88   6.07 (51.4%) 08-14 16:00
Open: 18.41 Pre. Close: 11.81
High: 19.6 Low: 16.25
Volume: 25,743,486 Market Cap: 2,143M
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage adult stem cells. The company's products under the Phase III clinical trials include MSC-100-IV for steroid refractory acute graft versus host disease; MPC-150-IM for advanced heart failure; and MPC-06-ID for chronic low back pain due to degenerative disc disease. It is also developing MPC-300-IV that is in Phase II clinical trials for the treatment of biologic refractory rheumatoid arthritis, diabetic kidney diseases, and type 2 diabetic nephropathy. It operates in the United States, Australia, Singapore, the United Kingdom, and Switzerland.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 19.618 - 19.713 19.713 - 19.795
Low: 16.057 - 16.15 16.15 - 16.231
Close: 17.729 - 17.885 17.885 - 18.021

Technical analysis

as of: 2020-08-14 4:32:11 PM
Overall:       
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 22.89     One year: 26.74
Support: Support1: 13.95    Support2: 10.46
Resistance: Resistance1: 19.60    Resistance2: 22.89
Pivot: 14.31
Moving Average: MA(5): 14.05     MA(20): 13.81
MA(100): 11.19     MA(250): 8.62
MACD: MACD(12,26): 0.56     Signal(9): 0.54
Stochastic oscillator: %K(14,3): 38.01     %D(3): 29.55
RSI: RSI(14): 63.59
52-week: High: 20.57  Low: 3.12  Change(%): 258.3
Average Vol(K): 3-Month: 94245  10-Days: 344333

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
MESO has closed below upper band by 3.5%. Bollinger Bands are 83.3% wider than normal. The large width of the bands suggest high volatility as compared to MESO's normal range. The bands have been in this wide range for 4 bars. This is a sign that the current trend might continue.

Headline News

Fri, 14 Aug 2020
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.12% - Investing.com

Fri, 14 Aug 2020
Why Mesoblast Stock Is Skyrocketing Today - Motley Fool

Thu, 13 Aug 2020
The Daily Biotech Pulse: Mesoblast Awaits Adcom Test, BioCryst Rallies On Insider Buying, Sorrento Hits Back At Short Seller - Yahoo Finance

Wed, 12 Aug 2020
Mesoblast Limited (NASDAQ:MESO) Finding Zero Support - The Oracle Dispatch

Tue, 11 Aug 2020
Mesoblast Plunges as FDA Questions Cell-Therapy Manufacturing - Motley Fool

Tue, 11 Aug 2020
More on Mesoblast ahead of Ad Com meeting on Ryoncil - Seeking Alpha

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability n/a
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency n/a
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 117
Shares Float (M) 84
% Held by Insiders
% Held by Institutions 2.10
Shares Short (K) 1,190
Shares Short P. Month (K) 839

Stock Financials

EPS -0.640
EPS Est This Year -0.770
EPS Est Next Year -0.420
Book Value (p.s.) 4.570
Profit Margin -197.64
Operating Margin -180.68
Return on Assets (ttm) -5.6
Return on Equity (ttm) -13.4
Qtrly Rev. Growth 876.9
Gross Profit (p.s.) 0.012
Sales Per Share 0.286
EBITDA (p.s.) -0.499
Qtrly Earnings Growth
Operating Cash Flow (M) -56
Levered Free Cash Flow (M) -22

Stock Valuations

PE Ratio -27.94
PEG Ratio
Price to Book value 3.91
Price to Sales 62.48
Price to Cash Flow -37.38

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.